LDN-214117

Product Name: LDN-214117
CAS No.: 1627503-67-6
Chemical Name: LDN-214117
Synonyms: CS-1539;LDN-214117;LDN-214117 USP/EP/BP;LDN-214117;LDN214117;1-(4-(6-methyl-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenyl)piperazine;1-[4-[6-Methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]piperazine;Piperazine, 1-[4-[6-methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]-;LDN214117,LDN-214117,ALK2,BMP4,BMP2,Transforming growth factor beta receptors,LDN 214117,BMP6,TGF-β Receptor,diffuse intrinsic pontine glioma(DIPG),oral,ALK3,fibrodysplasia ossificans progressiva (FOP),ALK5,type I receptor kinases,ALK1,bone morphogenetic proteins (BMPs)
CBNumber: CB92729368
Molecular Formula: C25H29N3O3
Formula Weight: 419.52
MOL File: 1627503-67-6.mol

More

Less

LDN-214117 Property

Boiling point:: 567.9±50.0 °C(Predicted)
Density: 1.134±0.06 g/cm3(Predicted)
storage temp.: 2-8°C
solubility: DMF:30.0(Max Conc. mg/mL);71.51(Max Conc. mM)
DMF:PBS (pH 7.2) (1:1):0.5(Max Conc. mg/mL);1.19(Max Conc. mM)
DMSO:42.67(Max Conc. mg/mL);101.7(Max Conc. mM)
Ethanol:54.0(Max Conc. mg/mL);128.72(Max Conc. mM)
pka: 8.86±0.10(Predicted)
form: Powder
color: Light yellow to yellow

More

Less

Safety

Hazard Codes: T
Risk Statements: 25
Safety Statements: 45

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

N-Bromosuccinimide Price

Cayman Chemical

Product number: 18006
Product name: LDN-214117
Purity: ≥98%
Packaging: 1mg
Price: $32
Updated: 2024/03/01

Cayman Chemical

Product number: 18006
Product name: LDN-214117
Purity: ≥98%
Packaging: 5mg
Price: $109
Updated: 2024/03/01

Cayman Chemical

Product number: 18006
Product name: LDN-214117
Purity: ≥98%
Packaging: 10mg
Price: $184
Updated: 2024/03/01

Cayman Chemical

Product number: 18006
Product name: LDN-214117
Purity: ≥98%
Packaging: 25mg
Price: $381
Updated: 2024/03/01

Tocris

Product number: 6152
Product name: LDN214117
Purity: ≥98%(HPLC)
Packaging: 10
Price: $208
Updated: 2021/12/16

More

Less

LDN-214117 Chemical Properties,Usage,Production

Uses

LDN 214117 is a highly selective ALK2 inhibitor.

LDN-214117 Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

LDN-214117 Suppliers

China 61 United Kingdom 1 United States 14 Global 76

Tocris Bioscience

Tel: --
Fax: --
Email: customerservice@tocris.co.uk
Country: United Kingdom
ProdList: 5726
Advantage: 77

1627503-67-6, LDN-214117Related Search:

LDN-212320 LDN-193189 HCl LDN-193189 LDN212854

1-[4-[6-Methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]piperazine

LDN-214117;LDN214117

CS-1539

LDN-214117

1-(4-(6-methyl-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenyl)piperazine

Piperazine, 1-[4-[6-methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]-

LDN-214117 USP/EP/BP

LDN214117,LDN-214117,ALK2,BMP4,BMP2,Transforming growth factor beta receptors,LDN 214117,BMP6,TGF-β Receptor,diffuse intrinsic pontine glioma(DIPG),oral,ALK3,fibrodysplasia ossificans progressiva (FOP),ALK5,type I receptor kinases,ALK1,bone morphogenetic proteins (BMPs)

1627503-67-6

Inhibitors